Hannah Joseph Hospital Limited has disclosed a significant share acquisition by its Promoter and Managing Director, Dr. Moses Joseph Arunkumar, under SEBI's insider trading regulations. The transaction demonstrates continued promoter confidence in the healthcare company's prospects.
Transaction Details
The share acquisition transaction presents the following key parameters:
Parameter: Details Shares Acquired: 3,84,000 equity shares Transaction Value: Rs. 2,66,04,672/- Transaction Date: March 27, 2026 Mode of Acquisition: On Market Exchange: BSE Average Price per Share: Rs. 69.28
Shareholding Pattern Changes
Dr. Moses Joseph Arunkumar's shareholding in the company has increased substantially following this acquisition:
Shareholding: Before Acquisition After Acquisition Change Number of Shares: 1,53,24,925 1,57,08,925 +3,84,000 Percentage Holding: 67.51% 69.21% +1.70%
Regulatory Compliance
The company received the disclosure from Dr. Arunkumar on March 28, 2026, pursuant to Regulation 7(2)(a) of the SEBI (Prohibition of Insider Trading) Regulations, 2015. The disclosure was made through Form C, which provides detailed information about changes in shareholding by promoters and designated persons.
Company Information
Hannah Joseph Hospital Limited operates as a healthcare institution specializing in neurosciences, cardiac sciences, orthopaedics, and traumatology. The company is listed on BSE with scrip code 544687 and symbol HANNAH. The hospital maintains NABH accreditation and operates NABL accredited laboratories, reflecting its commitment to quality healthcare standards.
Market Implications
The promoter's decision to increase shareholding through market purchases indicates strong confidence in the company's future performance. The acquisition strengthens promoter control while demonstrating commitment to the healthcare venture's long-term growth prospects.
Hannah Joseph Hospital Limited has announced that its promoter Dr. Moses Joseph Arunkumar has increased his stake in the company through a significant equity acquisition. The transaction represents a strategic move by the promoter to strengthen his position in the healthcare company.
Share Acquisition Details
Dr. Moses Joseph Arunkumar acquired 1,62,000 equity shares of Hannah Joseph Hospital Limited on March 19, 2026, through an on-market purchase on BSE. The transaction details are presented below:
Parameter: Details Number of Shares Acquired: 1,62,000 Transaction Value: Rs. 1,00,06,465 Date of Acquisition: March 19, 2026 Mode of Acquisition: Open Market Exchange: BSE
Shareholding Pattern Changes
The acquisition has resulted in a notable increase in Dr. Arunkumar's shareholding percentage in the company:
Shareholding Status: Before Acquisition After Acquisition Change Number of Shares: 1,51,62,925 1,53,24,925 +1,62,000 Percentage Holding: 66.80% 67.51% +0.71%
SEBI SAST Regulatory Compliance
The transaction has been disclosed under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. The disclosure was submitted to BSE Limited on March 20, 2026, with the company trading under scrip code 544687 and symbol HANNAH.
Persons Acting in Concert (PAC) Details
The regulatory filing also disclosed the shareholding pattern of persons acting in concert with Dr. Arunkumar:
PAC Member: Shareholding Percentage Dr. Fenn Kavitha Fenn Arunkumar: 4,32,000 shares 1.90% Mr. Daniel Dayanand Fenn: 8,015 shares 0.04% Mr. James Prabhukumar Moses: 29,430 shares 0.13% Dr. Arunkumar Nalina: 15 shares 0.00% Mr. Noyel Arunkumar: 15 shares 0.00% Total PAC Holdings: 4,69,475 shares 2.07%
Company Capital Structure
Hannah Joseph Hospital Limited has an equity share capital of Rs. 22,69,83,630 divided into 2,26,98,363 equity shares of Rs. 10 each. The total diluted share capital remains unchanged after this transaction. The combined holding of Dr. Arunkumar and PAC members now stands at 1,57,94,400 shares, representing 69.58% of the total share capital.
About Hannah Joseph Hospital Limited
Hannah Joseph Hospital Limited operates as a healthcare institution specializing in neurosciences, cardiac sciences, orthopaedics, and traumatology. The company holds NABH accreditation and operates NABL accredited laboratories, reflecting its commitment to quality healthcare services. The hospital is listed on BSE and continues to maintain its focus on providing comprehensive medical care.
We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.
Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.
As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation. We plan to change that - a technology-led platform built for super traders and long term investors.